MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
By Wei Li, Han Xu, Tengfei Xiao, Lê Công, Michael I. Love, Feng Zhang, Rafael A. Irizarry, Jun S. Liu, Myles A. Brown, X. S. Liu. Genome Biology, 2014
2,340 citations recorded by the source corpus.
We propose the Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK) method for prioritizing single-guide RNAs, genes and pathways in genome-scale CRISPR/Cas9 knockout screens. MAGeCK demonstrates better performance compared with existing methods, identifies both positively and negatively selected genes simultaneously, and reports robust results across different experimental conditions. Using public datasets, MAGeCK identified novel essential genes and pathways, including EGFR in vemurafenib-treated A375 cells harboring a BRAF mutation. MAGeCK also detected cell type-specific essential genes, including BCR and ABL1, in KBM7 cells bearing a BCR-ABL fusion, and IGF1R in HL-60 cells, which depends on the insulin signaling pathway for proliferation.
Subfields: Aging, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/3fcd6a0ae6a73c4e196dc13a994d7f12514fc53d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Aging
In Molecular Biology
- Lorrie Boucher
- Mike Tyers
- Chris Stark
- Bobby-Joe Breitkreutz
- Kara Dolinski
- Rose Oughtred
- Myles A. Brown
- X. S. Liu
Citations in the corpus
- A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia (2016, methodology): “However, when we applied statistical analyses (Li et al., 2014) to our own genome-wide screen data in mouse embryonic stem cells (ESCs), we were able to identify only a small number of genes depleted to significant levels (Figure 1A).”
- A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing (2018, methodology): “Candidate genes were plotted based on mean log2 fold change of gRNA counts compared to control selection and P values computed by MaGeCK (Model-based Analysis of Genome-wide CRISPR-Cas9 Knockout).”
- Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens (2019, neutral): “At the end of this stage, the following gene-level depletion score matrices were produced in each cell line: raw logFCs, copy number bias-corrected logFCs, BFs, scaled BFs, binary fitness scores and MAGeCK depletion FDRs.”
- The BioGRID interaction database: 2019 update (2018, background): “Curators thus capture details on original scoring schemes and analytical methods, which currently include BAGEL (78), CasTLE (79), CERES (80), MAGeCK (81), RANKS (82) and others.”
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities. (2015, positive): “Since BAGEL is designed to identify negatively selected genes, we used the MAGeCK algorithm (Li et al., 2014) and identified a number of positively selected genes from our screens.”
- Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR (2015, methodology): “sj is calculated by the ‘median ratio method’ in MAGeCK and DESeq2 [10, 37]:”